Drug Profile
Birch pollen allergy vaccine tablet - ALK-Abello
Alternative Names: Betula Verrucosa allergen extract; ITULAZAX; Oralgen Birch Pollen; SLIT birch pollen extract; SLITone Birch; SLITonePLUS Birch; SQ tree SLIT-tabletLatest Information Update: 13 Oct 2023
Price :
$50
*
At a glance
- Originator ALK-Abello
- Class Allergens; Peptide vaccines; Peptides; Skin disorder therapies; Tree pollen allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Allergic rhinoconjunctivitis
- Phase III Allergic conjunctivitis; Allergic rhinitis
Most Recent Events
- 11 Oct 2023 ALK-Abello plan to launch the tree pollen sublingual immunotherapy tablet for children and adolescents in Europe and Canada in 2025
- 11 Oct 2023 ALK-Abello plans to expand the Birch pollen allergy tablet for other indications
- 11 Oct 2023 Top-line safety and efficacy data from a phase III TreeTop trial in Allergy released by ALK-Abello 9400572